China 中国
Caffeine intake before exercise may aid breakdown of fats in overweight women
Taking caffeine 60 minutes before exercising may significantly improve the breakdown of fats in overweight and obese women, say new findings from China.
Sirio Pharma eyes Australia’s gummy supplement market with TGA-compliant range
Sirio Pharma is targeting growth in Australia’s gummy supplement market with the launch of a range of Therapeutic Goods Administration (TGA) compliant products.
Mitochondria for healthy aging: MitoQ New Zealand deepens Asia research with NUS
MitoQ New Zealand has signed a research partnership with the National University of Singapore (NUS) to assess the potential of mitochondria for healthy aging as it seeks to deepen research partnerships across Asia.
聚焦日本：功能性蛋白质、女性消费者健康关注点及更多内容
了解日本保健品市场的最新发展，包括功能性蛋白质领域的增长、女性消费者的健康关注点、最新研究发现等更多内容。
趋势追踪：印度蛋白质热潮、能量饮品、中国企业全球扩张
在本期新闻综述中，了解更多关于印度蛋白质消费热潮、中国能量饮料消费，以及中国企业如何加速海外市场扩张的信息。
科学短报：生姜提取物减重、南非醉茄增强运动能力及更多研究
本篇资讯重点介绍最新的健康与营养研究，包括关于蒸制生姜提取物减重、南非醉茄提升心肺适能等方面的新发现。
监管动态：穿心莲、咖啡因警示、生物制剂最新资讯
澳大利亚拟将穿心莲移出低风险原料目录、澳新地区运动食品需增设咖啡因标签警示，以及欧洲生物制剂法规更新，是本期监管资讯合集里的几项最新动态。
聚焦中国：BioGaia、功能性饮料需求、零售格局变化及更多资讯
本期综述涵盖多方面新闻，包括 BioGaia 的益生菌口腔健康补充剂、中国功能性饮料需求、零售格局变化、最新研究发现等。
China focus: BioGaia, functional drinks demand, shifts in retail landscape and more
This round-up looks at news including BioGaia’s probiotic oral health supplement, demand for functional drinks in China, shifts in retail landscape, latest research findings, and more.
HMO infant formulas: Regulatory developments to drive NPD and affordability
The growing number of regulatory approvals for human milk oligosaccharides (HMOs) in infant formulas is set to fuel product innovation and drive more affordable pricing in the long run.
VMS brands double down on e-commerce, Douyin in China
Health supplement brands from Centrum to BYHEALTH are doubling down on their e-commerce efforts in China, especially in Douyin, the Chinese version of TikTok.
Weizmannia coagulans BC99 presents promising probiotic strategy for chronic constipation
A study in China supports Weizmannia coagulans BC99’s potential to enhance intestinal motility, regulate gut microbiota and increase SCFA production.
聚焦日本：大冢制药、养乐多的肠道健康影响力、药物警戒等
了解日本营养保健品市场的最新发展，包括大冢制药的山柰酚补充剂及其在华扩张、一项新的药物警戒调查、养乐多在欧洲的肠道健康影响力等。
趋势追踪：中国保健食品贸易数据，印度营养保健品企业并购动态
在本期综合新闻中，了解更多关于去年中国保健食品贸易统计数据的趋势、印度营养保健品行业的一系列并购交易等信息。
科学短报：肌酸参考摄入量、咖啡果皮提取物与甜菜根
本期综合新闻重点介绍了最新的健康和营养研究，包括探讨为健康成年人制定肌酸膳食参考摄入量、咖啡果皮提取物降低胆固醇的潜力，以及运动员使用甜菜根汁的研究。
监管审查：保健食品出口、Magtein 批准等
本轮监管综合新闻中的最新动态包括：中国对海外生产的保健食品的工厂注册政策、Magtein 在英国获批，以及欧洲食品安全局 (EFSA) 对含小檗碱植物公开征求意见。
聚焦中国：阿里巴巴天猫热销品类、蛋白质消费等资讯汇总
本期综合新闻包括阿里巴巴天猫平台上销售收入最高的品类、中国的蛋白质消费增长与体重管理意识等。
China focus: Biggest sales categories on Alibaba Tmall, protein consumption and more
This round-up looks at news including the categories with biggest sales revenue on Alibaba Tmall, protein consumption growth and weight management awareness in China, and more.
Energy and sports drinks demand is robust in China, says Eastroc
There is “robust” demand for functional drinks such as energy beverages and sports drinks in China, says Eastroc, which reported a 17.3% increase in energy beverage sales and a 119% growth in sales of its sports drinks last year.
BLS extends import-export platform, lowering price of Chinese raw materials
Bioenergy Life Science (BLS) is expanding its global import export-platform to give U.S. manufacturers direct access to Chinese raw materials—without trader markups.
China’s retail landscape change: Douyin, Sam’s Club driving sales for Swisse
China’s health foods industry has been seeing declining sales from brick-and-mortar pharmacy chains and brands like Swisse are seeing Douyin and Sam’s Club as new growth channels.
Fighting fake imports? Health foods exported to China still need local authority recommendation
Overseas-made health foods entering China via the general trade route will still require official recommendation letters from their local authority when registering their manufacturing facility with the Chinese authorities - a move an industry expert...
‘Chinese firms’ overseas expansion a trend nowadays’: BYHEALTH speeds up new market entry
BYHEALTH, one of the largest dietary supplement companies in China, will speed up its overseas market expansion from this year - a move it says has become a general trend among Chinese companies across different industries.
Alibaba Tmall breaks down biggest health foods categories in China
Vitamin and mineral supplements, cardiovascular health supplements and kids nutrition are the three biggest nutraceutical categories in China in terms of sales revenue, according to major e-commerce channel Alibaba Tmall.
Protein users expanding in China, says BYHEALTH on new product launch
Protein consumption is growing in China across different consumer groups and demand for higher quality products is on the rise, says BYHEALTH, which has recently launched an upgraded version of its flagship protein powder product.
Weight management gaining attention in China, but actions still lacking: Junshi Chen
The general public in China now understands that body weight is something that should be controlled and managed, which Junshi Chen, chief consultant of China’s National Center for Food Safety Risk Assessment, believes is a key achievement of China’s...
Pharmacy chain founder opens nutraceutical longevity start-up
Margarita Zhao, founder of a pharmacy chain and a pharmaceutical company in Inner Mongolia, has launched a nutraceutical start-up focused on longevity and healthspan products - at least for its initial launch.
Trend tracker: China health foods trade data, India’s nutra firms M&A
Find out more about trends in China’s health foods trade statistics for last year, India’s string of merger and acquisition deals in the nutraceutical sector and more in this round-up.
聚焦日本：麒麟新设实体以及与子公司的研发合作、内服美容等更多动态
了解日本营养保健品市场的最新发展动态，包括麒麟集团成立新实体以及与子公司芳珂和澳佳宝推进免疫健康研发、亚太地区内服美容的增长驱动因素和市场机遇等。
趋势追踪：内服美容、能量袋装产品、NMN 等更多动态
本期综合新闻关注亚太地区内服美容市场趋势、能量袋装产品的兴起，以及澳大利亚烟酰胺单核苷酸 (NMN) 的零售现状。
科学短报：姜黄、大豆蛋白、药用蘑菇备受关注
本期综合新闻关注健康与营养领域的最新研究发现，包括姜黄掺假、大豆蛋白对肌肉健康的影响、药用蘑菇缓解焦虑的作用等内容。
监管审查：美国对中国和印度征收反倾销税、新 HMO 获批等更多动态
美国对某些国家的硬质空心胶囊征收反倾销税和反补贴税，以及中国批准 3′-唾液酸乳糖钠盐 (3′-SL) 用于婴幼儿配方奶粉——本期监管动态为您带来最新进展。
聚焦中国：a2 牛奶公司、大冢制药、HMO 获批等
本期综合新闻关注 a2 牛奶公司的婴幼儿营养业务、中国第三款 HMO 获批、大冢制药的新工厂、最新科学发现等内容。
China focus: a2 Milk Company, Otsuka Pharma, HMO approval and more
This round-up looks at news including a2 Milk Company’s infant nutrition business, the third HMO approval in China, Otsuka Pharma’s new factory, latest scientific findings and more.
Trade war impact: China’s health foods exports to the US slides 14.7% in 2025
The United States is China’s largest health foods export destination; however, exports were down 14.7% last year partly due to U.S. trade tariffs and changing trade policies.
Brand new: a2MC’s kids supplements debut, POCARI SWEAT factory, HUL acquisition
See new developments from health and nutrition brands across Asia-Pacific, including The a2 Milk Company’s kids supplements debut, POCARI SWEAT’s new factory and Hindustan Unilever (HUL) acquiring clean-label and women’s health firm OZiva.
China health foods stats: US still top exporter, Australia’s exports down 21.5%
The U.S. remained the top health foods exporter to China last year, followed by Germany where exports were up 15.5%, while Australia – once the top exporter between 2018 and 2020 – saw exports fall by 21.5%.
Haleon’s FY25 results: APAC supplements growth offsets US declines
Haleon saw strong sales growth in its health supplement business in Asia-Pacific last year, which it said has partly offset the decline in North America.
The a2 Milk Company to enter China’s pediatric supplements market
The a2 Milk Company is ramping up its infant nutrition business in China with the upcoming launch of four pediatric supplements in Q3 this year.
Otsuka Pharma beefs up POCARI SWEAT production in China
Otsuka Pharmaceutical Co. Ltd, the owner of the electrolyte drink POCARI SWEAT, is ramping up production in China with a newly opened factory in Tianjin.
Mengniu steps up health and nutrition push at 2026 Winter Olympics
Mengniu will supply dairy products to athletes and fans during the 2026 Winter Olympics, linking the move to its health and nutrition strategy
聚焦日本：FFC 最新发现、麒麟的研发布局及更多动态
本期内容聚焦日本营养保健品企业和行业的最新进展，包括功能性标示食品 (FFC) 报告的最新发现、麒麟集团的研发重点，以及大谷翔平 (Shohei Ohtani) 出任“免疫护理”推广大使等动态。
趋势追踪：越南营养品市场、台湾消费者对复合维生素的看法、日本 FFC
本期综合新闻关注越南快速增长的营养保健品市场、台湾消费者对复合维生素矿物质产品的认知，以及日本热门的功能性标示食品 (FFC) 动态。
科学短报：天门冬根提取物、L-苏糖酸镁备受关注
本期综合新闻关注健康与营养领域的最新研究发现，包括天门冬根提取物在调节血糖与血脂方面的作用、L-苏糖酸镁对认知表现的益处等。
监管审查：BPOM与HSA合作、中国审批动态及更多资讯
印尼国家药品与食品监督管理局 (BPOM) 与新加坡卫生科学局 (HSA) 就保健品开展联合评估，以及中国批准关节健康相关功能声明——本期监管动态为您带来最新进展。
聚焦中国：Orthomol 业务扩张、监管审批及更多动态
本期综合新闻聚焦 Orthomol 的扩张计划、监管审批最新进展，以及最新市场数据和科研成果。
China focus: Orthomol’s expansion, regulatory approvals and more
This round-up looks at news including Orthomol’s expansion ambitions, regulatory approvals, as well as latest data and scientific findings.
China approves HMO 3’-SL for use in infant formula
The Chinese authorities have approved 3’-sialyllactose (3’-SL) – a human milk oligosaccharide (HMO) – for use in infant formula for the first time.